1. Home
  2. RKT vs NVCR Comparison

RKT vs NVCR Comparison

Compare RKT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RKT

Rocket Companies Inc.

HOLD

Current Price

$14.02

Market Cap

44.0B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$11.97

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKT
NVCR
Founded
1985
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.0B
1.5B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
RKT
NVCR
Price
$14.02
$11.97
Analyst Decision
Buy
Buy
Analyst Count
16
6
Target Price
$20.93
$28.08
AVG Volume (30 Days)
25.7M
1.6M
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$66.62
$7.72
Revenue Next Year
$7.79
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$10.94
$9.82
52 Week High
$24.36
$20.05

Technical Indicators

Market Signals
Indicator
RKT
NVCR
Relative Strength Index (RSI) 37.00 46.41
Support Level $13.18 $10.86
Resistance Level $15.12 $13.93
Average True Range (ATR) 0.66 0.50
MACD 0.07 -0.11
Stochastic Oscillator 24.64 34.12

Price Performance

Historical Comparison
RKT
NVCR

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: